The noncompliant patient in psychiatry: The case for and against covert/surreptitious medication

Mens Sana Monographs

Volumn 8, Issue 1, 2010, Pages 96-121

  Latha, K S ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

Author keywords

Advance directives; Autonomy; Best Interests; Competency; Covert medication; Dignity; Informed Consent; Substitute Decision Maker; Surreptitious prescribing

Indexed keywords

EID: 75649104367     PISSN: 09731229     EISSN: 19984014     Source Type: Journal    
DOI: 10.4103/0973-1229.58822     Document Type: Article

References (53)

1. Ahern L., Van Tosh L., (2005), Taking Issue: The irreversible damage caused by surreptitious prescribing, Psychiatric Services, 56, p383.
2. Akhtar S., (1990), Mental Health Act 1987: Issues and Perspectives, Indian Journal of Psychological Medicine, 13(2), p196-200.
3. Akhtar S., Khess C.R.T., Sinha V.K., (1998), Human Rights of the Mentally ill: The scenario in India, Journal of Eastern Zonal Branch India. As cited by Antony J., (2000), A decade with mental health act 1987, IJP, 42(4), p347-355.
4. Appelbaum P.S., (1991), Advance directives for psychiatric treatment. Hospital and Community Psychiatry, 42, p983-984
5. Appelbaum, P S., (2004), Law & Psychiatry: Psychiatric Advance Directives and the Treatment of Committed Patients Psychiatric Services, 55, p751-763.
6. Beauchamp T.L., Childress J.F., (1994), Principles of biomedical ethics. New York: Oxford University Press
7. Berg J., Appelbaum P.S.; Lidz C.W., Parker L. (2001), Informed Consent: Legal Theory and Clinical Practice. 2nd ed. NY: Oxford University Press.
8. Breen R., Thornhill J.T., (1998), Noncompliance with medication for psychiatric disorders: reasons and remedies, CNS Drugs, 9, p457-471.
9. Brock D.W., (1993), A proposal for the use of advance directives in the treatment of incompetent mentally ill persons, Bioethics, 7, p47-56.
10. Chua S., Choy K., Wong J., (2001), Concealment of medication in patients' Food, The Lancet, 357, p1369.
11. College The, (2004), College Statement on Covert Administration of Medicines, Psychiatric Bulletin, 28, p385-386.
12. Griffith D., Bell A., (1996), Commentary: treatment was not unethical, British Medical Journal, 313, p1250.
13. Griffith R., (2003), Tablet crushing & the law" Pharmaceutical Journal, 271, p 90-91.
14. Grisso T., Appelbaum P.S., (1998), Assessing Competence to Consent to Treatment: A Guide for Physicians and Other Health Professionals. NY: Oxford University Press.
15. Guidelines for the Covert Administration of Medication, (2006), Medication Management Forum Ratified by: Blaise Mallon for Lezli Boswell 10th August 2006 (Royal College of Psychiatrists statement on covert administration of medicines 2004). Reviewed in December 2007 to incorporate the principles of the Mental Capacity Act 2005 (MCA 2005) Document Reference Code: MED/020/06, BMJ, 330 (1), Jan 2005, www.bmj.com.
16. Halpern A., Szmukler G., (1997), Psychiatric advance directives: reconciling autonomy and non-consensual treatment, Psychiatric Bulletin, 21, p323-327
17. Hargrave v Vermont, (2003), 340 F. 3d 27 (2nd Cir 2003).
18. Kellet J., (1996), A nurse is suspended. British Medical Journal, 313, p1249-1251.
19. Kelly M., Dunbar S., Gray J.E., O'Reilly R., (2002), Treatment delays for involuntary psychiatric patients associated with reviews of treatment capacity. Canadian Journal of Psychiatry 47, p181-185
20. Lavin M., (1986), Ulysses contracts, Journal of Applied Philosophy, 3, p89-101.
21. Loebel A.D., Lieberman J.A., Alvir J.M., Mayerhoff D.I, Geisler S.H., Szymanski S.R., (1992), Duration of psychosis and outcome in first episode schizophrenia, American Journal of Psychiatry, 149, p1183-1188.
22. Levin A., (2005), Professional News: Covert Drug Administration: ̀Win Battle, But Lose War' Psychiatric News, 40 (10), p10.
23. Mason J. K., Mccall Smith R. A., (1999), Law And Medical Ethics (5th Edn). London, Edinburgh And Dublin: Butterworths.
24. Matthew R. L., Lance M., Shalit M., Flavia N., (2006), An Unusual Case of Subterfuge in the Emergency Department: Covert Administration of Antipsychotic and Anxiolytic Medications to Control an Agitated Patient, Annals of Emergency Medicine, 47(1), p75-78.
25. McCullough L.B., Coverdale J.H., Chervenak F.A., (2007), 'Constructing a Systematic Review for Argument-Based Clinical Ethics Literature: The Example of Concealed Medications', Journal of Medicine and Philosophy, 32(1), p65 -76.
26. McEvoy J.P., Apperson L.J., Appelbaum P.S., Ortlip P., Brecosky J., Hammill K. et al., (1989), Insight in schizophrenia: its relation to acute psychopathology, Journal of Nervous and Mental Disease, 177, p43-47.
27. Nambi S., (1996), Legal Aspects of Psychiatry Indian, Journal of Psychological Medicine, 19(2), p19-39.
28. Norfolk and Norwich Healthcare NHS Trust v W [1996], 2 FLR 613Cited from Welsh S., Deahl M., (2002): Covert medication-ever ethically justifiable? Psychiatric Bulletin, 26, p123-126.
29. Norman R., Malla A., (2001), Duration of untreated psychosis: a critical examination of the concept and its importance. Psychological Medicine 31, p381-400.
30. Noroian P., (2005), Letters. Ethical Issues in Surreptitious Prescribing Psychiatric Services, 56, p1023.
31. Kirkevold O., Engedal K., (2005), Concealment of drugs in food and beverages in nursing homes: cross sectional study, BMJ, 330, p20.
32. Pilling S., Bebbington P., Kuipers E., Garety P., Geddes J., Martindale B., et al., (2002), Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy, Psychological Medicine, 32, p763-782.
33. RadcliffesLeBrasseur, (2003), Treatment without consent: breach of the human rights act? Available at: http://www.mentalhealthlawblog.co.uk/Repository/ 42/fi les/61-mhlb70- dec2003.pdf (Accessed 19 Dec 2009).
34. Re MB [1997], 2 FLR 426. Cited from Welsh S., Deahl M., (2002): Covert medication-ever ethically justifiable? Psychiatric Bulletin, 26, p123-126
35. Scott A.P., (1998), Professional Ethics: are we on the wrong track? Nursing Ethics, 5(6), p477-485
36. Scott H., William E.R., (1997), Suspension of nurse who gave drug on consultant's instructions. Concealed administration of drug treatment may represent thin end of the wedge. British Medical Journal. 314,300-301
37. Scottish Executive, (2000), The Adults with incapacity (Scotland) Act 2000, Scottish Executive: Edinburgh.
38. Sellwood W., Tarrier N., Quinn J., Barrowclough C., (2003), The family and compliance in schizophrenia: the influence of clinical variables, relatives' knowledge and expressed emotion, Psychological Medicine 33, p91-96.
39. Singh A.R., (2008), Covert Treatment in Psychiatry: Do No Harm, True, But Also Dare to Care, Mens Sana Monographs, 6(1), p81-109.
40. Singh S.P., (2007), Outcome measures in early psychosis: Relevance of duration of untreated psychosis, British Journal of Psychiatry, 191, s58-63.
41. Srebnik DS, La Fond JQ(1999), Advance directives for mental health treatment. Psychiatric Services 50:p919-25.
42. Srinivasan T., Thara, R. (2002), At issue: Management of medication noncompliance in schizophrenia by families in India, Schizophrenia Bulletin, 28, p531-535.
43. Stroup S., Swartz M., Appelbaum P., (2002), Concealed medicines for people with schizophrenia: A U. S. perspective, Schizophrenia Bulletin, 28, p537-542.
44. Swanson J.W., Tepper M.C., Backlar P., Schwarz M., (2000), Psychiatric advance directives: an alternative to coercive treatment? Psychiatry 63, p160-177.
45. Swanson J., Swartz M., Ferron J., Elbogen E., Van Dorn R., (2006), Psychiatric advance directives among public mental health consumers in fi ve U.S. Cities: prevalence, demand and correlates, Journal of American Academy of Psychiatry & Law , 34 (1), p43-57.
46. Szasz T., (1982), The psychiatric will: a new mechanism for protecting persons against "psychosis" and psychiatry, American Psychologist, 37, p762-770.
47. Treloar A., Beats B., Philpot M., (2000), A pill in the sandwich: covert medication in food and drink, Journal of the Royal Society of Medicine 93, p408-411.
48. Treolar A., Philpot M., Beats B., (2001), Concealing medication patients' food, The Lancet, 357, p62-64.
49. Valmana A., Rutherford J., (1997), Suspension of nurse who gave drug on consultant's instructions: over a third of psychiatrists had given a drug surreptitiously or lied about a drug, BMJ, 314, p300.
50. Welsh S., Deahl M., (2002), Covert medication-ever ethically justifiable? Psychiatric Bulletin 26, p123-126.
51. Widdershoven G., Berghmans R., (2001), Advance directives in psychiatric care: a narrative approach Journal of Medical Ethics 27, p92-97. (Pubitemid 32297578)
52. Whitty P., Devitt P., (2005), Opinions on-Surreptitious prescribing in psychiatric practice, Psychiatric Services, 56, p481-483.
53. Wong J.G.W.S., Poon Y., Hui E.C., (2005), I can put the medicine in his soup, doctor! Journal of Medical Ethics, 31, p262-265.